CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oppenheimer Adjusts Aardvark Therapeutics Price Target to $21 From $35, Maintains Outperform Rating

Negative
AI Analysis

Summary

Oppenheimer reduced its price target for Aardvark Therapeutics from $35 to $21 while maintaining an Outperform rating, indicating a significant valuation adjustment.

Importance:3/10
Sentiment:
-0.40
price_target_reductionanalyst_ratingvaluation
Related Companies

Read the original article

Published by yahoo_finance on March 2, 2026 1:54 PM

Read Original